Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER_GOV × Tablets × Clear all

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

OTHER 14 INDUSTRY 4 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

pembrolizumab 9 Drug Therapy 8 Bevacizumab 8 Cyclophosphamide 6 Carboplatin 6 Capecitabine 6 tislelizumab 5 Surgical Procedures, Operative 5 Radiotherapy 5 Paclitaxel 5 Oxaliplatin 5 Nivolumab 5 Docetaxel 5 Immune Checkpoint Inhibitors 4 Gemcitabine 4 Fluorouracil 4 Endoscopic Mucosal Resection 4 Control Groups 4 Cisplatin 4 pegylated granulocyte colony-stimulating factor 3 fludarabine 3 Neoadjuvant Therapy 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Cytarabine 3 sintilimab 2 lenvatinib 2 human papillomavirus vaccine, L1 type 16, 18 2 fludarabine phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05722795 2025-07-09

I-CONIC

Vastra Gotaland Region

Phase NA Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡